In every issue, you’ll find the hottest topics of interest to our readers along with cutting-edge health information.
Also Available On:
Exploring intersectionality through poetry
Coping with the fight for change
Exploring LGBT and HIV intersectionality is the theme of this special issue.
Author Armistead Maupin also shares insights about married life, bathhouses and his scandalous relationship with Rock Hudson.
“And So It Happened” profiles people taking HIV treatment and PrEP.
LGBT and HIV themes abound in these latest offerings.
At this year’s AIDSWatch, activists called out CDC director Robert Redfield for the health agency’s patent rights on Truvada for PrEP.
A look at June issues from the POZ archives
Here are some important dates in AIDS history.
Long-term survivor Bob Leahy talks about what HIV looks like in 2019 versus 1989.
A social media recap of our March 2019 issue on U=U.
A second man’s virus went into remission following an HIV-resistant stem cell transplant to treat his cancer.
Given every four weeks, the combo injection of cabotegravir and Edurant (rilpivirine) will likely face an FDA decision by early 2020.
HIV-positive people with a higher viral load over a longer period appear more likely to develop hepatocellular carcinoma.
Gay and bisexual men with HIV who are cured of hep C are reinfected at a high rate.
Truvada and Descovy are both highly effective and generally safe options for HIV prevention.
An early trial of Gilead’s HIV capsid inhibitor supports three-month dosing.
A new, more accurate HIV reservoir test is a big advance for cure research.
According to a systematic review and meta-analysis of dozens of studies, people with HIV have high rates of cardiac dysfunction
Dee Dee Chamblee is a transgender activist in Atlanta.
Read the digital edition!